Company Overview and News
Rox Resources has been busy since winning Explorer of the Year at the 2015 Australian Mining Prospect Awards.
Marindi Metals has signed a memorandum of understanding entitling a government-owned Japanese group to earn a 70 per cent stake in the company’s Caranbirini zinc project in the Northern Territory.
Marindi Metals has signed a memorandum of understanding with a government-owned Japanese group to earn a 70 per cent stake in the company’s Caranbirini zinc project in the Norther Territory.
Marindi Metals Ltd (ASX:MZN) has found conglomerate gold at a second site within the Bellary Dome project in the Pilbara region of Western Australia.
Marindi Metals Ltd (ASX:MZN) has completed a sampling program at the Cosmic Boy and Digger Rocks prospects, part of its Forrestania Lithium Project in Western Australia.
Marindi Metals Ltd (ASX:MZN) is undertaking a placement and a fully underwritten non-renounceable entitlement offer to raise up to $4.4 million.
SYDNEY, Nov 30 (Reuters) - Canada-based Kirkland Lake Gold listed its shares on the Australia bourse on Thursday after investing millions of dollars and joining dozens of other prospectors in a modern-day gold rush.
SYDNEY (Reuters) - Canada-based Kirkland Lake Gold will list its shares on the Australia bourse on Thursday after investing millions of dollars and joining dozens of other prospectors in a modern-day gold rush.
Marindi Metals Ltd (ASX:MZN) is preparing to reveal details from the Bellary Project, with the ASX granting a trading halt to prepare.
Marindi Metals Ltd’s (ASX:MZN) shares closed circa 55% higher on Friday after securing an option to acquire a tenement prospective for gold-bearing conglomerates in the Pilbara Basin.
Marindi Metals Ltd (ASX:MZN) is yet another explorer boosting its portfolio in recent months, and the company is preparing to reveal details of an option to acquire a tenement.
IT’S the biggest punt going in Australia — $1 billion and counting — and Gary Morgan can’t get a bet on.
Marindi Metals (ASX:MZN) has confirmed the potential for conglomerate hosted gold based on its recent field visits to the Newman Project, 400 kilometres southeast of Karratha, Western Australia.
Lithium spot and contract price news - No change from last month; up 9.81% in the past year.
Marindi Metals has conceded defeat in its Supreme Court fight against Kidman Resources over rights to the Mt Holland lithium operation, but will receive a settlement payout from Rox Resources over a separate matter.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...